P Schroth

2.1k total citations
21 papers, 1.6k citations indexed

About

P Schroth is a scholar working on Cognitive Neuroscience, Hematology and Clinical Psychology. According to data from OpenAlex, P Schroth has authored 21 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cognitive Neuroscience, 8 papers in Hematology and 5 papers in Clinical Psychology. Recurrent topics in P Schroth's work include Hemophilia Treatment and Research (8 papers), Autism Spectrum Disorder Research (8 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). P Schroth is often cited by papers focused on Hemophilia Treatment and Research (8 papers), Autism Spectrum Disorder Research (8 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). P Schroth collaborates with scholars based in United States, United Kingdom and Sweden. P Schroth's co-authors include Bruce M. Ewenstein, Victor S. Blanchette, Gerald Spotts, M. Oh, S. Fritsch, Kathelijn Fischer, M H Maxwell, Maroun Karam, Edward Ritvo and Peter W. Collins and has published in prestigious journals such as The Lancet, American Journal of Psychiatry and Journal of Autism and Developmental Disorders.

In The Last Decade

P Schroth

21 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Schroth United States 17 964 268 258 146 130 21 1.6k
Ron Pedersen United States 25 417 0.4× 130 0.5× 54 0.2× 36 0.2× 233 1.8× 55 1.8k
Enrico Fusaro Italy 22 115 0.1× 45 0.2× 94 0.4× 66 0.5× 98 0.8× 84 1.2k
Kyriaki Papadopoulou‐Legbelou Greece 11 55 0.1× 56 0.2× 79 0.3× 107 0.7× 42 0.3× 41 552
Lingli Zhang China 12 92 0.1× 24 0.1× 58 0.2× 24 0.2× 85 0.7× 52 562
Katy Gallop United Kingdom 16 63 0.1× 42 0.2× 50 0.2× 15 0.1× 67 0.5× 42 774
Eilidh MacDonald United Kingdom 8 407 0.4× 12 0.0× 19 0.1× 159 1.1× 18 0.1× 16 1.1k
John Hanson Canada 16 82 0.1× 38 0.1× 64 0.2× 8 0.1× 34 0.3× 20 880
P Millac United Kingdom 17 38 0.0× 27 0.1× 22 0.1× 54 0.4× 30 0.2× 45 1.1k
J. Tsao United States 11 57 0.1× 62 0.2× 36 0.1× 73 0.5× 70 0.5× 24 367
Kavita Gajria United States 16 39 0.0× 26 0.1× 116 0.4× 20 0.1× 96 0.7× 24 768

Countries citing papers authored by P Schroth

Since Specialization
Citations

This map shows the geographic impact of P Schroth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Schroth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Schroth more than expected).

Fields of papers citing papers by P Schroth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Schroth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Schroth. The network helps show where P Schroth may publish in the future.

Co-authorship network of co-authors of P Schroth

This figure shows the co-authorship network connecting the top 25 collaborators of P Schroth. A scholar is included among the top collaborators of P Schroth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Schroth. P Schroth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valentino, Leonard A., Vasily Mamonov, Andrzej Hellmann, et al.. (2011). A randomized comparison of two prophylaxis regimens and a paired comparison of on‐demand and prophylaxis treatments in hemophilia A management. Journal of Thrombosis and Haemostasis. 10(3). 359–367. 203 indexed citations
2.
Fischer, Kathelijn, Peter W. Collins, Sven Björkman, et al.. (2011). Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trials. Haemophilia. 17(3). 433–438. 36 indexed citations
3.
Björkman, Sven, Victor S. Blanchette, Kathelijn Fischer, et al.. (2010). Comparative pharmacokinetics of plasma‐ and albumin‐free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age‐related differences and implications for dose tailoring. Journal of Thrombosis and Haemostasis. 8(4). 730–736. 99 indexed citations
4.
Collins, Peter W., Sven Björkman, Kathelijn Fischer, et al.. (2009). Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens. Journal of Thrombosis and Haemostasis. 8(2). 269–275. 147 indexed citations
5.
Collins, P., Jan Astermark, Sven Björkman, et al.. (2008). The importance of maintaining FVIII through levels above 1% during prophylactic treatment of hemophilia A: using license study databases to answer key medical questions. Lund University Publications (Lund University). 3 indexed citations
6.
Collins, P., Victor S. Blanchette, Kathelijn Fischer, et al.. (2008). Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A. Journal of Thrombosis and Haemostasis. 7(3). 413–420. 262 indexed citations
7.
Blanchette, Victor S., Amy D. Shapiro, Ri Liesner, et al.. (2008). Plasma and albumin‐free recombinant factor VIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients. Journal of Thrombosis and Haemostasis. 6(8). 1319–1326. 120 indexed citations
8.
9.
Freeman, B. J., Edward Ritvo, A Mason-Brothers, et al.. (1989). Psychometric assessment of first-degree relatives of 62 autistic probands in Utah. American Journal of Psychiatry. 146(3). 361–364. 48 indexed citations
10.
Yuwiler, Arthur, Edward Geller, P Schroth, et al.. (1986). Fenfluramine treatment of autism: UCLA collaborative study of 81 patients at nine medical centers.. PubMed. 22(1). 133–40. 61 indexed citations
11.
Mh, Maxwell, et al.. (1985). Obesity and hypertension: long-term effects of weight reduction on blood pressure.. PubMed. 9(6). 381–9. 43 indexed citations
12.
Freeman, B. J., Edward Ritvo, & P Schroth. (1984). Behavior Assessment of the Syndrome of Autism: Behavior Observation System. Journal of the American Academy of Child Psychiatry. 23(5). 588–594. 35 indexed citations
13.
Maxwell, M H, et al.. (1982). ERROR IN BLOOD-PRESSURE MEASUREMENT DUE TO INCORRECT CUFF SIZE IN OBESE PATIENTS. The Lancet. 320(8288). 33–36. 221 indexed citations
14.
Freeman, B. J., et al.. (1981). Behavior Observation System for Autism: Analysis of Behaviors among Autistic, Mentally Retarded, and Normal Children. Psychological Reports. 49(1). 199–208. 1 indexed citations
15.
Freeman, B. J., et al.. (1981). Behavioral characteristics of high- and low-IQ autistic children. American Journal of Psychiatry. 138(1). 25–29. 58 indexed citations
16.
Freeman, B. J., et al.. (1980). The Behavior Observation Scale for autism (BOS): Initial results of factor analyses. Journal of Autism and Developmental Disorders. 10(3). 343–346. 19 indexed citations
17.
Freeman, B. J., D. Guthrie, Edward Ritvo, et al.. (1979). Behavior Observation Scale: Preliminary Analysis of the Similarities and Differences between Autistic and Mentally Retarded Children. Psychological Reports. 44(2). 519–524. 20 indexed citations
18.
Freeman, Betty Jo, et al.. (1978). The Behavior Observation Scale for Autism: Initial Methodology, Data Analysis, and Preliminary Findings on 89 Children. Journal of the American Academy of Child Psychiatry. 17(4). 576–588. 45 indexed citations
19.
Weidmann, P, et al.. (1972). Plasma aldosterone in patients with end stage kidney disease.. PubMed. 9. 147–53. 3 indexed citations
20.
Schroth, P, et al.. (1968). Automatic control of ultrafiltration.. PubMed. 14. 415–20. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ron Pedersen Breakdown of academic impact, for papers by Enrico Fusaro Breakdown of academic impact, for papers by Kyriaki Papadopoulou‐Legbelou Breakdown of academic impact, for papers by Lingli Zhang Breakdown of academic impact, for papers by Katy Gallop Breakdown of academic impact, for papers by Eilidh MacDonald Breakdown of academic impact, for papers by John Hanson Breakdown of academic impact, for papers by P Millac Breakdown of academic impact, for papers by J. Tsao Breakdown of academic impact, for papers by Kavita Gajria
Rankless by CCL
2026